LICENSING AGREEMENTS (Details Textual) - USD ($)		1 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Feb. 02, 2016	Sep. 30, 2016	Dec. 31, 2016
Amortization of Intangible Assets	$ 0			$ 9,356
Payments to Acquire Intangible Assets	0			10,000
Finite-Lived Intangible Assets, Net	$ 0			100,644
Patents [Member]
Stock Issued During Period, Value, Purchase of Assets				100,000
Finite-Lived Intangible Assets, Net				90,876
Finite Lived Intangible Assets, Expected Annual Amortization				10,000
Licensing Agreements [Member]
Payments to Acquire Intangible Assets				5,000
Reimbursement of License fees				$ 1,800
Shares Issued, Price Per Share				$ 0.01
Royalty Expense				$ 7,800
Royalty Payment Percentage				6.00%
Non-Royalty Sublease Income Percentage				25.00%
Payments for Royalties			$ 20,000	$ 50,000
Finite-Lived Intangible Assets, Net				9,768
Finite Lived Intangible Assets, Expected Annual Amortization				$ 1,200
Licensing Agreements [Member] | Restricted Stock [Member]
Stock Issued During Period, Shares, Purchase of Assets				323,333
Stock Issued During Period, Value, Purchase of Assets				$ 1,000
Multipotent Amniotic Fetal Stem Cells License Agreement [Member] | Patents [Member]
Finite-Lived Intangible Asset, Expiration Period		2026
Amortization of Intangible Assets				232
Creative Medical Health, Inc [Member] | Patents [Member]
Stock Issued During Period, Shares, Purchase of Assets		64,666,667
Stock Issued During Period, Value, Purchase of Assets		$ 100,000
Finite-Lived Intangible Asset, Expiration Period		2025
Amortization of Intangible Assets				$ 9,124